Small-scale farming of freshwater crustaceans could be a win-win for communities in developing countries where schistosomiasis is prevalent.
Scientists have provided a roadmap through which the appetite for snails can be controlled in freshwater prawns and curb the transmission of the dangerous parasites, also known as “blood flukes.” These parasites cause schistosomiasis, the second most devastating parasitic disease worldwide, after malaria.// Before bite-sized crustaceans like crayfish, shrimp and prawns land on our dinner plates, they first have to get fat themselves -- and it turns out they relish the freshwater snails that transmit the parasite that causes schistosomiasis.
‘Schistosomiasis, also known as ‘snail fever’ spreads primarily through contaminated water and is known to cause stunted growth and cognitive impairment in children and thereby reducing productivity as adults.’
The study, which appears in the journal Nature Sustainability, shows how small-scale farming of freshwater prawns -- also known as aquaculture -- could be a win-win for communities in emerging and developing economies where schistosomiasis is common. "River prawns are common aquaculture products in settings around the world, and we know these organisms are voracious predators of the snails that transmit schistosomiasis," said UC Berkeley's Christopher Hoover, a doctoral student in the School of Public Health's Division of Environmental Health Sciences who led the study. "What has not been clear is if we could marry the economic benefits of prawn aquaculture with the disease-control activity of the prawns."
Aquaculture is growing rapidly in settings around the world and has the potential to alleviate mounting pressures on wild fisheries. Freshwater prawns are already being produced in aquaculture systems around the world, from Louisiana to Thailand to Senegal and beyond.
In these aquaculture systems, juvenile prawns are first raised in hatchery facilities, then stocked in waterways where schistosomiasis is transmitted, and finally harvested once they reach a marketable size. As the prawns grow, they feed on the snails that carry the schistosome parasite.
The parasite is incapable of infecting the prawns themselves, and schistosomiasis is not transmitted via ingestion, so raising, harvesting and consuming prawns cannot pass along the disease.
Advertisement
"Our results show that there are highly beneficial configurations of prawn aquaculture systems that minimize tradeoffs between generating revenue from harvesting prawns and reducing schistosomiasis transmission," Hoover said. "We can design systems to maximize profit while having a substantial impact on disease reduction, potentially helping to lift populations out of poverty in emerging and developing economies."
Advertisement
By acting on the environmental component of the transmission cycle -- the intermediate host snail population -- prawn-based interventions can complement drug treatment, yielding greater population benefits.
The model showed that, to reduce parasite loads, introducing native prawns to infected waterways was comparable to the standard approach of widescale administration of schistosomiasis-fighting drugs, and that it could decrease the parasite burden to nearly zero after 10 years.
Prawns may have environmental benefits, as well, including substituting for chemical pesticides to control snail populations and restoring native biodiversity in areas where native prawn species have been decimated by dams.
"Chris' research contributes a new tool to our global efforts to combat schistosomiasis," said Justin Remais, head of the Division of Environmental Health Sciences and co-senior author of the study. "Poverty and schistosomiasis are intrinsically linked, and transmission of the parasite is known to stunt growth and cognitive development in children and to prevent adults from working, reinforcing poverty. By targeting transmission of the parasite itself, while also supporting a locally-sourced production system where economic benefits accrue to the community, this approach has great potential to supplement ongoing disease control campaigns that generally rely on drug treatment alone."
Source-Eurekalert